The effect of metformin on the hypothalamic-pituitary-thyroid axis in patients with type 2 diabetes and subclinical hyperthyroidism

Experimental and Clinical Endocrinology and Diabetes

Volumn 123, Issue 4, 2015, Pages 205-208

  Krysiak, R ^a   Szkrobka, W ^a   Okopien, B ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

diabetes mellitus; hyperthyroidism; hypothalamic pituitary thyroid axis; metformin

Indexed keywords

GLIMEPIRIDE PLUS METFORMIN; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; LIOTHYRONINE; LIOTRIX; METFORMIN; THYROTROPIN; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; THYROXINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG EFFECT; DRUG WITHDRAWAL; FEMALE; FLATULENCE; FREE THYROXINE INDEX; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; HYPOTHALAMUS HYPOPHYSIS THYROID SYSTEM; INSULIN RESISTANCE; LIOTHYRONINE BLOOD LEVEL; MALE; MEDICAL HISTORY; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SUBCLINICAL HYPERTHYROIDISM; THYROID FUNCTION TEST; THYROTROPIN BLOOD LEVEL; ADOLESCENT; BLOOD; COMPLICATION; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; HYPERTHYROIDISM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; THYROID GLAND; YOUNG ADULT;

ADOLESCENT; ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTHYROIDISM; HYPOGLYCEMIC AGENTS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INSULIN RESISTANCE; MALE; METFORMIN; MIDDLE AGED; THYROID FUNCTION TESTS; THYROID GLAND; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE; YOUNG ADULT;

EID: 84927598456     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0034-1398621     Document Type: Article

References (18)

1. American Diabetes Association Standards of medical care in diabetes - 2013. Diabetes Care: 2013; 36 01 S11 S66
2. UK Prospective Diabetes Study Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet: 1998; 352 854 865
3. Genuth S. The UKPDS and its global impact. Diabet Med: 2008; 25 02 57 62
4. Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med: 2002; 346 393 403
5. Scarpello J. H., Howlett H. C. Metformin therapy and clinical uses. Diab Vasc Dis Res: 2008; 5 157 167
6. Mahmood K., Naeem M., Rahimnajjad N. A. Metformin: the hidden chronicles of a magic drug. Eur J Intern Med: 2013; 24 20 26
7. Vigersky R. A., Filmore-Nassar A., Glass A. R. Thyrotropin suppression by metformin. J Clin Endocrinol Metab: 2006; 91 225 227
8. Cappelli C., Rotondi M., Pirola I. et al. TSH-lowering effect of metformin in type 2 diabetic patients: differences between euthyroid, untreated hypothyroid, and euthyroid on L-T4 therapy patients. Diabetes Care: 2009; 32 1589 1590
9. Isidro M. L., Penín M. A., Nemiña R. et al. Metformin reduces thyrotropin levels in obese, diabetic women with primary hypothyroidism on thyroxine replacement therapy. Endocrine: 2007; 32 79 82
10. Morteza Taghavi S., Rokni H., Fatemi S. Metformin decreases thyrotropin in overweight women with polycystic ovarian syndrome and hypothyroidism. Diab Vasc Dis Res: 2011; 8 47 48
11. Cappelli C., Rotondi M., Pirola I. et al. Metformin-induced thyrotropin suppression is not associated with cardiac effects. Hormones (Athens): 2014; 13 252 258
12. Turnbridge W. M., Evered D. C., Hall R. et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol: 1977; 7 481 493
13. Díez J. J., Iglesias P. Relationship between serum thyrotropin concentrations and metformin therapy in euthyroid patients with type 2 diabetes. Clin Endocrinol: 2013; 78 505 511
14. Krysiak R., Okopien B. Thyrotropin-lowering effect of metformin in a patient with resistance to thyroid hormone. Clin Endocrinol: 2011; 75 404 406
15. Davis S. N. The role of glimepiride in the effective management of Type 2 diabetes. J Diabetes Complications: 2004; 18 367 376
16. Prince R. L., Worth G. K., Shenfield G. M. Sulphonylurea therapy and hypothyroidism. Practitioner: 1980; 224 1287 1289
17. England M. L., Hartnell J. M., Hershman J. M. et al. Glyburide does not alter thyroid function. Diabetes Res: 1986; 3 471 474
18. Szybiński Z. Polish Council for Control of Iodine Deficiency Disorders: Work of the Polish Council for Control of Iodine Deficiency Disorders, and the model of iodine prophylaxis in Poland. Endokrynol Pol: 2012; 63 156 160